{"resourceType":"ValueSet","id":"mcode-histology-morphology-behavior-vs","text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\"><h2>Histology Morphology Behavior Value Set</h2><div><p>Codes representing the structure, arrangement, and behavioral characteristics of malignant neoplasms, and cancer cells. Inclusion criteria: in situ neoplasms and malignant neoplasms. Exclusion criteria: benign neoplasms and neoplasms of unspecified behavior. Note: As the vocabulary binding is extensible within this IG, ICD-O-3 morphology codes (including behavior suffix) may also be used; they are not included in the value set for intellectual property reasons. For primary cancers, the ICD-O-3 behavior suffix should be /1, /2, or /3. For secondary cancers, the ICD-O-3 behavior suffix should be /6. Only SNOMED CT and ICD-O-3 are considered conformant to the specification. However, to be compliant with US Core Profiles, ICD-O-3 may only be used if there is no suitable code in SNOMED CT.</p>\n</div><ul><li>Include codes from <a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a> where concept  is-a  367651003 (Malignant Neoplasm (Morphology))</li><li>Include codes from <a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a> where concept  is-a  399919001 (Carcinoma in situ - category (morphologic abnormality))</li><li>Include codes from <a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a> where concept  is-a  399983006 (In situ adenomatous neoplasm - category (morphologic abnormality))</li><li>Include these codes as defined in <a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=399878004\">399878004</a></td><td>Malignant neoplasm with pilar differentiation (morphologic abnormality)</td><td/></tr><tr><td><a href=\"http://browser.ihtsdotools.org/?perspective=full&amp;conceptId1=253035009\">253035009</a></td><td>In situ melanocytic morphology (morphologic abnormality)</td><td/></tr></table></li><li>Exclude codes from <a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a> where concept  is-a  450893003 (Papillary neoplasm, pancreatobiliary-type, with high grade intraepithelial neoplasia (morphologic abnormality))</li><li>Exclude codes from <a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a> where concept  is-a  128640002 (Prostatic intraepithelial neoplasia, grade III)</li><li>Exclude codes from <a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a> where concept  is-a  450890000 (Glandular intraepithelial neoplasia, low grade)</li><li>Exclude codes from <a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a> where concept  is-a  703548001 (Atypical hyperplasia of the endometrium)</li></ul><p>This value set includes codes based on the following rules:</p></div>"},"url":"http://hl7.org/fhir/us/mcode/ValueSet/mcode-histology-morphology-behavior-vs","version":"1.0.0","name":"HistologyMorphologyBehaviorVS","title":"Histology Morphology Behavior Value Set","status":"active","date":"2020-03-18T15:32:10+00:00","publisher":"HL7 International Clinical Interoperability Council","contact":[{"name":"HL7 International Clinical Interoperability Council","telecom":[{"system":"url","value":"http://www.hl7.org/Special/committees/cic"},{"system":"email","value":"ciclist@lists.HL7.org"}]}],"description":"Codes representing the structure, arrangement, and behavioral characteristics of malignant neoplasms, and cancer cells. Inclusion criteria: in situ neoplasms and malignant neoplasms. Exclusion criteria: benign neoplasms and neoplasms of unspecified behavior. Note: As the vocabulary binding is extensible within this IG, ICD-O-3 morphology codes (including behavior suffix) may also be used; they are not included in the value set for intellectual property reasons. For primary cancers, the ICD-O-3 behavior suffix should be /1, /2, or /3. For secondary cancers, the ICD-O-3 behavior suffix should be /6. Only SNOMED CT and ICD-O-3 are considered conformant to the specification. However, to be compliant with US Core Profiles, ICD-O-3 may only be used if there is no suitable code in SNOMED CT.","compose":{"include":[{"system":"http://snomed.info/sct","filter":[{"property":"concept","op":"is-a","value":"367651003"}]},{"system":"http://snomed.info/sct","filter":[{"property":"concept","op":"is-a","value":"399919001"}]},{"system":"http://snomed.info/sct","filter":[{"property":"concept","op":"is-a","value":"399983006"}]},{"system":"http://snomed.info/sct","concept":[{"code":"399878004","display":"Malignant neoplasm with pilar differentiation (morphologic abnormality)"},{"code":"253035009","display":"In situ melanocytic morphology (morphologic abnormality)"}]}],"exclude":[{"system":"http://snomed.info/sct","filter":[{"property":"concept","op":"is-a","value":"450893003"}]},{"system":"http://snomed.info/sct","filter":[{"property":"concept","op":"is-a","value":"128640002"}]},{"system":"http://snomed.info/sct","filter":[{"property":"concept","op":"is-a","value":"450890000"}]},{"system":"http://snomed.info/sct","filter":[{"property":"concept","op":"is-a","value":"703548001"}]}]}}